IXHL Stock Analysis: Buy, Sell, or Hold?
IXHL - Incannex Healthcare Limited American Depositary Shares
$2.90
-0.06 (-2.03%)
▼
5d:
-14.96%
30d:
-26.77%
90d:
+710.06%
WAIT
LOW Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When IXHL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IXHL is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IXHL is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.59
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.71
38.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IXHL is currently trading at $2.90, which is considered fair relative to its 30-day fair value range of $1.07 to $4.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.3) compared to its historical average (4.3). Remarkably, the market is currently pricing in an annual earnings decline of 18.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IXHL is in a strong uptrend. Immediate support is located at $2.78, while resistance sits at $3.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IXHL is in a strong uptrend. Immediate support is located at $2.78, while resistance sits at $3.68.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.07 -
$4.37
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- WARNING: Recommendation downgraded due to -15.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.07 -
$4.37
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.78
Resistance Level
$3.68
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.30
Revenue Growth (YoY)
-100.0%
Valuation Discount vs History
-18.7% cheaper
PE vs Historical
2.3 vs 4.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.7%
(market-implied from PE analysis)
1-Year Target
$2.61
(-10%)
2-Year Target
$2.35
(-19%)
3-Year Target
$2.11
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→4)
$3.95
(+36%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.3 to 4.3
Stabilization Target:
$5.42
(+86.8%)
PE Expansion Potential:
+86.8%
Share & Embed Analysis
Last updated: April 05, 2026 8:47 AM ET
Data refreshes hourly during market hours. Next update: 9:47 AM
Data refreshes hourly during market hours. Next update: 9:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IXHL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 63 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 56 HOLD |
